Your institution may have access to this item. Find your institution then sign in to continue.
Title
Use of low-dose mitozantrone to treat aggressive multiple sclerosis: a single-centre open-label study using patient self-assessment and clinical measures of multiple sclerosis status.
Authors
Ostberg, A; Pittas, F; Taylor, B
Abstract
There is significant evidence supporting the use of mitozantrone in the treatment of multiple sclerosis (MS) but few data on the subtypes of MS that respond or which measures of disease status are most useful.
Publication
Internal medicine journal, 2005, Vol 35, Issue 7, p382